| For: | Lim CY, Khay SL. Bleeding complications after percutaneous kidney biopsies – nationwide experience from Brunei Darussalam. World J Nephrol 2023; 12(5): 147-158 [PMID: 38230299 DOI: 10.5527/wjn.v12.i5.147] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v12/i5/147.htm |
| Number | Citing Articles |
| 1 |
Allison B. Reiss, Berlin Jacob, Aarij Zubair, Ankita Srivastava, Maryann Johnson, Joshua De Leon. Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets. Journal of Clinical Medicine 2024; 13(7) doi: 10.3390/jcm13071881
|
| 2 |
Shunye Su, Yan Zhu, Guiyan Han, Zhentao Zhang, Liqin Liang, Yuan Gao. Eculizumab for ATCR-associated de novo thrombotic microangiopathy in a Chinese kidney transplant recipient with type 2 diabetes: a case report. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1872856
|
| 3 |
YiFei Xu, Weidong Huang, Xuelian Wu, Honghua Lv, Qiankun Zhang, Wenhui Lei. Lower eGFR is independently associated with embolization‑requiring severe bleeding after percutaneous renal biopsy: a matched case–control study with dose–respons e analysis. Renal Failure 2026; 48(1) doi: 10.1080/0886022X.2026.2714663
|